The role of genomic and antigenomic HCV-RNA strands as predictive factors of response to pegylated interferon plus ribavirin therapy

MLA

Vicente Carreño, et al. “The Role of Genomic and Antigenomic HCV-RNA Strands as Predictive Factors of Response to Pegylated Interferon plus Ribavirin Therapy.” Alimentary Pharmacology & Therapeutics, vol. 25, Mar. 2007, pp. 1193–201. EBSCOhost, https://doi.org/10.1111/j.1365-2036.2007.03314.x.

APA

Vicente Carreño, Inmaculada Castillo, Juan Antonio Quiroga, Maria Eugenia Castellanos, Margarita Pardo, Javier Bartolomé, Elena Rodríguez-Iñigo, & Juan Manuel López-Alcorocho. (2007). The role of genomic and antigenomic HCV-RNA strands as predictive factors of response to pegylated interferon plus ribavirin therapy. Alimentary Pharmacology & Therapeutics, 25, 1193–1201. https://doi.org/10.1111/j.1365-2036.2007.03314.x

Chicago

Vicente Carreño, Inmaculada Castillo, Juan Antonio Quiroga, Maria Eugenia Castellanos, Margarita Pardo, Javier Bartolomé, Elena Rodríguez-Iñigo, and Juan Manuel López-Alcorocho. 2007. “The Role of Genomic and Antigenomic HCV-RNA Strands as Predictive Factors of Response to Pegylated Interferon plus Ribavirin Therapy.” Alimentary Pharmacology & Therapeutics 25 (March): 1193–1201. doi:10.1111/j.1365-2036.2007.03314.x.